Welcome
November 7, 2009

 
tickerspy ResearchWire
 
Sands Stocks Mixed Amid Oil Selloff
11/6/09 

Much of the energy-tied equity sector got beat up on Friday, but upgrades and earnings kept sands stocks alive.

So far it appears the August merger of Suncor Energy (SU) and PetroCanada has worked out well. The former, now the largest oil…

Posted by Owen Vater at 11:54AM on November 6th | No Comments »
Homebuyers Rejoice, Homebuilders Take a Dive
11/6/09 

The U.S. House of Representatives voted Thursday to extend and expand the first-time homebuyers’ tax credit.

Earlier this year, in an effort to stabilize the badly bruised housing market, the government offered an $8000 tax credit to first time homebuyers. Now,…

Posted by Owen Vater at 11:10AM on November 6th | No Comments »
Gold Sends Miners on a 10% Weekly Pop
11/6/09 

Equity investors continued to shrug off the seemingly ever-growing unemployment rate on Friday, but that didn’t stop commodity investors from bidding gold to a new record high.

In a consumer-driven economy like the U.S., logic suggests that higher unemployment figures should…

Posted by Owen Vater at 9:59AM on November 6th | No Comments »
Placing Bets On Human Genome’s Benlysta
11/5/09 

There has been a lot of hype surrounding Human Genome Sciences’ (HGSI) lupus drug recently.

To those who bet on Human Genome Sciences before its mid-July leap, congratulations, you are now rich. Buyers who got in ahead of the latest spike at…

Posted by Owen Vater at 12:35PM on November 5th | No Comments »
Buffett’s Value-Focused Neighbor Likes Cable Stocks, Berkshire Shares
11/5/09 

Warren Buffett isn’t the only value investor in Omaha. Weitz Funds president and portfolio manager Wallace Weitz has seen all five of his equity funds appreciate by over 20% in 2009. Newly disclosed holdings indicate a preference for the cable…

Posted by Owen Vater at 11:02AM on November 5th | No Comments »
The $2000 Swine Flu Drug
11/5/09 

The peramivir pricing speculation is over, and the first order has been shipped.

The U.S. FDA issued BioCryst Pharmaceuticals (BCRX) emergency use authorization for its swine flu antiviral in October, but at that point a price had not been settled. In an…

Posted by Owen Vater at 9:53AM on November 5th | No Comments »
Three Hot Dividend Sectors You Might Be Missing
11/4/09 

These sectors have outperformed the market while paying out some of the highest yields around.

Various segments of the energy and real estate sector pay some of the highest dividend yields, and recently a handful of these groups have averaged gained…

Posted by Owen Vater at 11:49AM on November 4th | No Comments »
It’s Not All Penny Stocks in Nanotech
11/4/09 

Strong earnings lifted the nanotech sector on Wednesday.

Hillsboro, Oregon-based nano-scale imaging and analysis instrument firm FEI Co. (FEIC) reported a 60% sequential jump to 16 cents in third-quarter EPS. The company also topped last year’s third-quarter EPS figure of 11…

Posted by Owen Vater at 11:03AM on November 4th | No Comments »
STEC Shares Crushed on Near-Term Outlook
11/4/09 

A weaker-than-expected near-term outlook for STEC (STEC) led shares to plunge by -30% on Wednesday.

STEC reported EPS in line with the 47-cent consensus and topped revenue expectations in the third quarter, however the company’s outlook through early 2010 has investors dumping…

Posted by Owen Vater at 10:31AM on November 4th | No Comments »
What’s Next for Billionaire Oilman Pickens?
11/4/09 

Though much slimmed down after a disastrous 2008, legendary oilman T. Boone Pickens’ hedge fund portfolio has been faring well.

2008 was brutal for Pickens. BP Capital, his energy-focused hedge fund, had fallen by about -60% on the year through late…

Posted by Max Magee at 9:17AM on November 4th | No Comments »